Schedule 13G ownership disclosure
Adaptimmune Therapeutics PLC
Security class unavailable · CUSIP: 75N996220
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.0170%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-15-002670
- Form type
- SC 13G
- Filer
- Adaptimmune Therapeutics PLC
- CIK
- CIK 1621227
- Filed
- May 11, 2015
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership